Altered prostate growth and daily sperm production in male mice exposed prenatally to subclinical doses of 17α-ethinyl oestradiol

Human Reproduction

Volumn 16, Issue 5, 2001, Pages 988-996

  Thayer, K A ^a,d   Ruhlen, R L ^a   Howdeshell, K L ^a   Buchanan, D L ^b   Cooke, P S ^b   Preziosi, D ^a   Welshons, W V ^a   Haseman, J ^c   Vom Saal, F S ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d WORLD WILDLIFE FUND   (United States)

Author keywords

Endocrine disruption; Fetus; Oral contraceptive; Prostate; Testes

Indexed keywords

17ALPHA ESTRADIOL; ANDROGEN RECEPTOR; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOCRINE GLAND MALFORMATION; FETUS (ANATOMY); GESTATION PERIOD; MALE GENITAL TRACT MALFORMATION; NONHUMAN; PREGNANCY; PRENATAL DRUG EXPOSURE; PROSTATE; SPERMATOGENESIS; TESTIS; TISSUE GROWTH;

EID: 0035021958     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.5.988     Document Type: Article

References (62)

1. American College of Obstetrics and Gynecology (1993) Contraceptives and congenital anomalies. ACOG committee opinion: Committee on gynecologic practice. Number 124-July 1993. Int. J. Gynaecol. Obstet., 42, 316-317.
2. Akpoviroro, J. and Fotherby, K. (1980) Assay of ethinyl oestradiol in human serum and its binding to plasma proteins. J. Steroid Biochem., 13, 773-779.
3. Alworth, L., Howdeshell, K., Ruhlen, R. et al. (1999) Uterine response to estradiol: low-dose facilitation and high-dose inhibition due to fetal exposure to diethylstilbestrol and methoxychlor in CD-1 mice. Paper presented at the Environmental Hormones meeting. Tulane University, New Orleans, LA.
4. Bern, H.A., Edery, M., Mills, K.T. et al. (1987) Long-term alterations in histology and steroid receptor levels of the genital tract and mammary gland following neonatal exposure of female balb/ccrgl mice to various doses of diethylstilbestrol. Cancer Res., 47, 4165-4172.
5. Berndtson, W.E. and Thompson, T.L. (1990) Changing relationships between testis size, Sertoli cell number and spermatogenesis in Sprague-Dawley rats. J Androl., 11, 429-435.
6. Bibbo, M., Gill, W.B., Azizi, F. et al. (1977) Follow-up study of male and female offspring of DES-exposed mothers. Obstet. Gynecol., 49, 1-8.
7. Blair, P.B., Noller, K.L., Turiel, J. et al. (1992) Disease patterns and antibody responses to viral antigens in women exposed in utero to diethylstilbestrol. In Colborn, T. and Clement, C. (eds), Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton Scientific Publishing Company, Inc., Princeton, pp. 283-288.
8. Branham, W.S., Zehr, D.R., Chen, J.J. et al. (1988) Uterine abnormalities in rats exposed neonatally to diethylstilbestrol, ethynylestradiol, or clomiphene citrate. Toxicology, 51, 201-212.
9. Brown, R.E., Jarvis, K.L. and Hyland, K.J. (1989) Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal. Biochem., 180, 136-139.
10. Colborn, T. and Clement, C. (eds) (1992) Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton Scientific Publishing Company, Inc., Princeton.
11. Cooke, P.S., Hess, R.A., Porcelli, J. et al. (1991) Increased sperm production in adult rats after transient neonatal hypothyroidism. Endocrinology, 129, 244-248.
12. DeSesso, J.M. (1997) Comparative embryology. In Hood, R.D. (ed.), Handbook of Developmental Toxicology. CRC Press, New York, pp. 111-174.
13. Dunn, T. and Green, A. (1963) Cysts of the epididymis, cancer of the cervix, granular cell myoblastoma, and other lesions after estrogen injection in newborn mice. J. Natl Cancer Inst., 31, 425-438.
14. Gill, W.B., Schumacher, G.F. and Bibbo, M. (1976) Structural and functional abnormalities in the sex organs of male offspring of mothers treated with diethylstilbestrol (DES). J. Reprod. Med., 16, 147-153.
15. Giusti, R.M., Iwamoto, K. and Hatch, E.E. (1995) Diethylstilbestrol revisited: a review of the long-term health effects. Ann. Intern. Med., 122, 778-788.
16. Gray, L.E. (1992) Chemical-induced alterations of sexual differentiation: A review of effects in humans and rodents. In Colborn, T. and Clement, C. (eds), Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton Scientific Publishing Company, Inc., Princeton, pp. 203-230.
17. Gupta, C. (2000) Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc. Soc. Exp. Biol. Med., 224, 61-68.
18. Harada, S., Takayama, S., Shibano, T. et al. (1991a) Fertility study of oral contraceptives dt-5061 and dt-5062 (1/35) in rats. Yakuri To Chiryo, 19, 157-196.
19. Harada, S., Takayama, S., Shibano, T. et al. (1991b) Teratogenicity study of oral contraceptives dt-5061 and dt-5062 (1/35) in rats. Yakuri To Chiryo, 19, 197-231.
20. Herbst, A.L. (1981) Diethylstilbestrol and other sex hormones during pregnancy. Obstet. Gynecol., 58, 35S-40S.
21. Herbst, A.L., Scully, R.E. and Robboy, S.J. (1979) Prenatal diethylstilbestrol exposure and human genital tract abnormalities. Natl Cancer Inst. Monogr., 25-35.
22. Hines, M. (1992) Surrounded by estrogens? Considerations for neurobehavioral development in human beings. In Colborn, T. and Clement, C. (eds). Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton Scientific Publishing Company, Inc., Princeton, pp. 261-282.
23. Hite, R.C., Bannemerschult, R., Fox-Kuchenbecker, P. et al. (1999) Large observational trial of a new low-dose oral contraceptive containing 20 micrograms ethinylestradiol and 100 micrograms levonorgestrel (Miranova) in Germany. Eur. J. Contracept. Reprod. Health Care, 4, 7-13.
24. Joyce, K.L., Porcelli, J. and Cooke, P.S. (1993) Neonatal goitrogen treatment increases adult testis size and sperm production in the mouse. J. Androl., 14, 448-455.
25. Kallen, B., Mastroiacovo, P., Lancaster, P.A. et al (1991) Oral contraceptives in the etiology of isolated hypospadias. Contraception, 44, 173-182.
26. Kavlock, R.J. and Ankley, G.T. (1996) A perspective on the risk assessment process for endocrine-disruptive effects on wildlife and human health. Risk Anal, 16, 731-739.
27. Kluin, P.M., Kramer, M.F. and de Rooij, D.G. (1984) Proliferation of spermatogonia and Sertoli cells in maturing mice. Anat. Embryol., 169, 73-78.
28. Labarca, C. and Paigen, K. (1980) A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem., 102, 344-352.
29. Li, D.K. (1998) Reply to 'Prenatal exposure to sex hormones: a case-control study' (letter). Teratology, 58, 1.
30. Li, D.K., Daling, J.R., Mueller, B.A. et al. (1995) Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies. Teratology, 51, 30-36.
31. Martinez-Frias, M.L., Rodriguez-Pinilla, E., Bermejo, E. et al. (1998) Prenatal exposure to sex hormones: a case-control study. Teratology, 57, 8-12.
32. McLachlan, J.A., Newbold, R.R., Shah, H.C. et al. (1982) Reduced fertility in female mice exposed transplacentally to diethylstilbestrol (DES). Fertil. Steril., 38, 364-371.
33. Mittendorf, R. (1995) Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero. Teratology, 51, 435-445.
34. Nagel, S.C., vom Saal, F.S. and Welshons, W.V. (1998) The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity. Proc. Soc. Exp. Biol. Med., 217, 300-309.
35. National Research Council (1999) Hormonally active agents in the environment. National Academy Press, Washington, DC.
36. Newbold, R. (1995) Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ. Health Perspect., 103, 83-87.
37. Newbold, R.R., Jefferson, W.N. and Banks, E.P. (1999) Developmental exposure to low doses of diethylstilbestrol (DES) results in permanent alterations in the reproductive tract. Poster presented at the Endocrine Society. San Diego, CA.
38. Nonneman, D.J., Ganjam, V.K., Welshons, W.V. et al. (1992) Intrauterine position effects on steroid metabolism and steroid receptors of reproductive organs in male mice. Biol. Reprod., 47, 723-729.
39. Paulozzi, L.J. (1999) International trends in rates of hypospadias and cryptorchidism. Environ. Health Perspect., 107, 297-302.
40. Raman-Wilms, L., Tseng, A.L., Wighardt, S. et al. (1995) Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet. Gynecol., 85, 141-149.
41. Reel, J.R., Lamb, I.J. and Neal, B.H. (1996) Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fundam. Appl. Toxicol., 34, 288-305.
42. Robb, G.W., Amann, R.P. and Killian, G.J. (1978) Daily sperm production and epididymal sperm reserves of pubertal and adult rats. J. Reprod. Fertil., 54, 103-107.
43. Shah, H.C. and McLachlan, J.A. (1976) The fate of diethylstilbestrol in the pregnant mouse. J Pharmacol. Exp. Ther., 197, 687-696.
44. Sharpe, R.M. and Skakkebaek, N.E. (1993) Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet, 341, 1392-1395.
45. Slikker, W., Jr., Bailey, J.R., Newport, D. et al. (1982) Placental transfer and metabolism of 17 alpha-ethynylestradiol-17 beta and estradiol-17 beta in the rhesus monkey. J. Pharmacol. Exp. Ther., 223, 483-489.
46. Smithells, R.W. (1981) Oral contraceptives and birth defects. Dev. Med. Child Neurol., 23, 369-372.
47. Stillman, R.J. (1982) In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring. Am. J. Obstel. Gynecol., 142, 905-921.
48. Swan, S.H., Elkin, E.P. and Fenster, L. (1997) Have sperm densities declined? A reanalysis of global trend data. Environ. Health Perspect., 105, 1228-1232.
49. Swan, S.H. and vom Saal, F.S. (2001) Alterations in male reproductive development: the role of endocrine disrupting chemicals. In Metzler, M. (ed.), Endocrine Disruptors in the Environment. Springer-Verlag, Heidelberg (in press).
50. Takasugi, N. and Bern, H. (1964) Tissue changes in mice with persistent vaginal cornification induced by early postnatal treatment with estrogen. J. Natl Cancer Inst., 33, 855-865.
51. Taylor, J.A., Grady, L.H., Engler, K.S. and Welshons, W.V. (1995) Relationship of growth stimulated by lithium, estradiol and EGF to phospholipase C activity in MCF-7 human breast cancer cells. Breast Cancer Res. Treat., 34, 265-277.
52. Toppari, J., Larsen, J.C., Christiansen, P. et at. (1996) Male reproductive health and environmental xenoestrogens. Environ. Health Perspect., 104 (Suppl. 4), 741-803.
53. Vergouwen, R.P., Jacobs, S.G., Huiskamp, R. et al. (1991) Proliferative activity of gonocytes, Sertoli cells and interstitial cells during testicular development in mice. J. Reprod. Fertil., 93, 233-243.
54. vom Saal, F.S., Timms, B.G., Montano, M.M. et al. (1997) Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc. Natl Acad. Sci. USA, 94, 2056-2061.
55. Walker, A.H., Bernstein, L., Warren, D.W. et al. (1990) The effect of in utero ethinyl oestradiol exposure on the risk of cryptorchid testis and testicular teratoma in mice. Br. J. Cancer, 62, 599-602.
56. Wilcox, A.J., Baird, D.D., Weinberg, C.R. et al. (1995) Fertility in men exposed prenatally to diethylstilbestrol. N. Engl. J. Med., 332, 1411-1416.
57. Yasuda, Y., Kihara, T. and Tanimura, T. (1985a) Effect of ethinyl estradiol on the differentiation of mouse fetal testis. Teratology, 32, 113-118.
58. Yasuda, Y., Kihara, T., Tanimura, T. et al. (1985b) Gonadal dysgenesis induced by prenatal exposure to ethinyl estradiol in mice. Teratology, 32, 219-227.
59. Yasuda, Y., Konishi, H., Matuso, T. et al. (1986a) Accelerated differentiation in seminiferous tubules of fetal mice prenatally exposed to ethinyl estradiol. Anat. Embryol., 174, 289-299.
60. Yasuda, Y., Konishi, H. and Tanimura, T. (1986b) Leydig cell hyperplasia in fetal mice treated transplacentally with ethinyl estradiol. Teratology, 33, 281-288.
61. Yasuda, Y., Konish, H. and Tanimura, T. (1987) Ovarian follicular cell hyperplasia in fetal mice treated transplacenlally with ethinyl estradiol. Teratology, 36, 35-43.
62. Yasuda, Y., Ohara, I., Konishi, H. et al. (1988) Long-term effects on male reproductive organs of prenatal exposure to ethinyl estradiol. Am. J. Obstet. Gynecol., 159, 1246-1250.